Carl A. Pinkert

University of Rochester, Rochester, NY 
Pathology, Cell Biology, Genetics
"Carl Pinkert"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Moos WH, Faller DV, Glavas IP, et al. (2020) Klotho Pathways, Myelination Disorders, Neurodegenerative Diseases, and Epigenetic Drugs. Bioresearch Open Access. 9: 94-105
Moos WH, Faller DV, Glavas IP, et al. (2018) A New Approach to Treating Neurodegenerative Otologic Disorders. Bioresearch Open Access. 7: 107-115
Moos WH, Faller DV, Glavas IP, et al. (2017) Epigenetic Treatment of Neurodegenerative Ophthalmic Disorders: An Eye Toward the Future. Bioresearch Open Access. 6: 169-181
Moos WH, Pinkert CA, Irwin MH, et al. (2016) Epigenetic Treatment of Persistent Viral Infections. Drug Development Research
Moos WH, Maneta E, Pinkert CA, et al. (2016) Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia. Drug Development Research
Irwin MH, Moos WH, Faller DV, et al. (2016) Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases. Drug Development Research
Steliou K, Faller DV, Pinkert CA, et al. (2015) Bioprotective carnitinoids: lipoic acid, butyrate, and mitochondria-targeting to treat radiation injury: mitochondrial drugs come of age. Drug Development Research. 76: 167-75
Parameshwaran K, Irwin MH, Steliou K, et al. (2015) Antioxidant-mediated reversal of oxidative damage in mouse modeling of complex I inhibition. Drug Development Research. 76: 72-81
Cannon MV, Irwin MH, Pinkert CA. (2015) Mitochondrially-imported RNA in drug discovery. Drug Development Research. 76: 61-71
Dunn DA, Pinkert CA. (2015) Allotopic expression of ATP6 in the mouse as a transgenic model of mitochondrial disease. Methods in Molecular Biology (Clifton, N.J.). 1265: 255-69
See more...